T1	Participants 715 772	55 healthy young men depending on their CD38 gene variant
T2	Participants 928 960	Homozygotic risk allele carriers
T3	Participants 1230 1262	homozygotic risk allele carriers
T4	Participants 1476 1489	allele groups
